Article PDF
Avoid common mistakes on your manuscript.
Literatur
Gajdusek, D. C.: Infectious amyloids: Subacute spongiform encephalopathies as transmissible cerebral amyloidoses. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3d edition), Philadelpia: Lippincott-Raven (1996) 2851–2900.
Prusiner, S. P.: Prisons. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3d edition), Philadelpia: Lippincott-Raven (1996) 2901–2950.
Diringer, H.: Durchbrechen von Speziesbarrieren mit unkonventionellen Viren. Bundesgesundhbl.33 (1990) 435–440.
Chesebro, B., and Fields, B. N.: Transmissible spongiform encephalopathies: a brief introduction. In: Fields, B. N., Knipe, D. M., Howley, P. M., et al.: Virology (3rd edition), Philadelphia: Lippincott-Raven, (1996) 2845–2849.
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R. A., Augenried, P., Aguet, M., and Weissmann, C.: Mice devoid of PrP are resistant to scrapie. Cell93 (1993) 1339–1347.
Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., and Smith, P. G.: A new variant of Creutzfeldt-Jakob disease in the UK. Lancet347 (1996) 921–925.
Zeidler, M., Stewart, G. E., Barraclough, C. R., Bateman, D.E., Bates, D., Burn, D.J., Colchester, A.C., Durward, W., Fletcher, N. A., Hawkins, S.A., Mackenzie, J. M., and Will, R. G.: New Variant Creutzfeldt-Jacob disease: neurological features and diagnostic tests. Lancet350 (1997) 903–907.
Chazot, G., Brousolle, E., Lapras, C., Blättler, T., Aguzzi, A., and Kopp, N.: New variant of Creutzfeldt-Jakob disease in a 26-year-old french man. Lancet347 (1996) 1181.
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., and Hill, A. F.: Molecular analysis of prion strain variation and the aetiology of »new variant« CJD. Nature383 (1996) 685–90.
Bruce, M. E., Will, R. D., Ironside, J. W., McConnell, I., Drummond, D., Suttle, A., McCardle, L., Chree, A., Hope, J., Birkett, C., Cousens, S., Fraser, H., and Bostock, C. J.: Transmissions to mice indicate that »new variant« CJD is caused by the BSE agent. Nature389 (1997) 498–501.
Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. T. S., Gowland, I., and Collinge, J.: The same prion strain causes vCJD and BSE. Nature389 (1997) 448–450.
Brown, P., Preece, M. A., and Will, R. G.: »Friendly fire« in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet340 (1992) 24–27.
Zerr, I., Bodemer, M., Räcker, S., Grosche, S., Poser, S., Kretzschmar, H. A., and Weber, T.: Cerebrospinal fluid concentration of neuronspecific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet345 (1995) 1609–1610.
Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H., and Harrington, M. G.: The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med.335 (1996) 924–930.
Simon, D.: Zusammenhänge zwischen menschlichen und tierischen übertragbaren spongiformen Enzephalopathien. RKI InfFo I/97 1–6.
Desinfektion und Sterilisation von chirurgischen Instrumenten bei Verdacht auf Creutzfeldt-Jakob-Erkrankungen. Bundesgesundhbl.39 (1996) 282–283.
Hill, A. F., Zeidler, M., Ironside, J., and Collinge, J.: Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet349 (1997) 99–100.
Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Bundesgesundhbl.39 (1996) 468–489.
Löwer, J.: Creutzfeldt-Jakob-Erkrankung: Zur Diskussion um das Risiko einer Übertragung durch Blut und Blutprodukte. Bundesgesundhbl.39 (1996) 284–289.
Glück, D., Elbert, G., Dengler, T., Gossrau, E., Gräßmann, W., Grimm, M., Holzberger, G., Sternberger, J., Weise, W., und Kubanek, B.: HIV-Lookback-Studie der DRK-Blutspendedienste in der BRD. Infusionsther. Transfusionsmed.21 (1994) 368–375.
Ricketts, M. N., Cashman, N. R., Stratton, E. E., and ElSaadany, S.: Is Creutzfeldt-Jakob disease transmitted in blood? Emerging Infectious Diseases3 (1997) 155–163.
Operskalski, E. A., and Mosley, J. W.: Pooled plasmaderivatives and Creutzfeldt-Jakob disease. Lancet346 (1996) 1223.
Brown, P.: Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr. Opin. Hematol.2 (1995) 472–477.
Masson, C., Delalande, I., Deslys, J. P., Hénin, D., Fallet-Bianco, C., Dormont, D., and Leys, D.: Creutzfeldt-Jakob disease after pituitaryderived human growth hormone therapy: Two cases with valine 129 homozygous genotype. Neurology44 (1994) 179–180.
Créange, A., Gray, F., Cesaro, P., Adle-Biasette, H., Duvoux, C., Cherqui, D., Bell, J., Parchi, P., Gambetti, P., and Degos, J.-D.: Creutzfeldt-Jakob disease after liver transplantation. Ann. Neurol.38 (1995) 269–272.
Klein, R., and Dumble, L. J.: Transmission of Creutzfeldt-Jakob disease by blood transfusion. Lancet341 (1993) 768.
Esmonde, T. F. G., Will, R. G., Slattey, J. M., Knight, R., Harries-Jones, R., de Silva, R., and Matthews, W. B.: Creutzfeldt-Jakob disease and blood transfusion. Lancet341 (1993) 205–207.
Wientjens, D. P. W. M., Davinipour, Z., Hofman, A., Kondo, K., Matthews, W. B., Will, R. G., and van Duijn, C. M.: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology46 (1996) 1287–1291.
Heye, N., Hensen, S., and Müller, N.: Creutzfeldt-Jakob disease and blood transfusion. Lancet343 (1994) 298–299.
WHO Report of a WHO consultation on medicinal and other products in relation to human and animal transmissible spongiform encephalopathies. WHO/EMC/ZOO/97.3-WHO/BLG/97.2 (1997).
Rights and permissions
About this article
Cite this article
Greutzfeldt-Jakob-Erkrankung (CJK) bzw. humane übertragbare (transmissible) spongiforme Enzephalopathien (TSE). Bundesgesundhbl. 41, 78–83 (1998). https://doi.org/10.1007/BF03043183
Issue Date:
DOI: https://doi.org/10.1007/BF03043183